Goldman Sachs’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130M Buy
1,258,596
+392,898
+45% +$44.5M 0.02% 883
2025
Q4
$87.3M Sell
865,698
-313,365
-27% -$34M 0.01% 1087
2025
Q3
$145M Buy
1,179,063
+605,988
+106% +$75.2M 0.02% 740
2025
Q2
$68.8M Sell
573,075
-133,930
-19% -$17.9M 0.01% 1129
2025
Q1
$104M Buy
707,005
+421,453
+148% +$64.4M 0.02% 763
2024
Q4
$46.4M Sell
285,552
-314,688
-52% -$51.5M 0.01% 1360
2024
Q3
$97.8M Sell
600,240
-129,633
-18% -$19.2M 0.02% 806
2024
Q2
$99.6M Buy
729,873
+269,554
+59% +$37.4M 0.02% 799
2024
Q1
$70.5M Sell
460,319
-57,297
-11% -$8.55M 0.01% 970
2023
Q4
$73.8M Sell
517,616
-335,602
-39% -$44.7M 0.01% 933
2023
Q3
$112M Buy
853,218
+71,365
+9% +$10.8M 0.02% 663
2023
Q2
$124M Sell
781,853
-41,411
-5% -$6.68M 0.03% 622
2023
Q1
$130M Buy
823,264
+416,675
+102% +$62.5M 0.03% 573
2022
Q4
$57.1M Sell
406,589
-18,305
-4% -$2.6M 0.01% 1068
2022
Q3
$54.6M Sell
424,894
-28,118
-6% -$4.06M 0.01% 1065
2022
Q2
$63.9M Buy
453,012
+62,498
+16% +$8.93M 0.02% 961
2022
Q1
$54.3M Sell
390,514
-216,082
-36% -$33.1M 0.01% 1204
2021
Q4
$106M Buy
606,596
+178,636
+42% +$29.8M 0.02% 778
2021
Q3
$70.9M Sell
427,960
-40,098
-9% -$6.91M 0.02% 986
2021
Q2
$84.2M Sell
468,058
-85,064
-15% -$15.5M 0.02% 845
2021
Q1
$107M Buy
553,122
+85,956
+18% +$16.5M 0.03% 614
2020
Q4
$94.3M Buy
467,166
+15,853
+4% +$3.28M 0.02% 651
2020
Q3
$94.9M Sell
451,313
-435,165
-49% -$96.9M 0.03% 604
2020
Q2
$194M Sell
886,478
-323,684
-27% -$64.7M 0.06% 314
2020
Q1
$210M Buy
1,210,162
+442,365
+58% +$73.1M 0.07% 254
2019
Q4
$118M Sell
767,797
-43,285
-5% -$6.47M 0.03% 615
2019
Q3
$123M Sell
811,082
-119,226
-13% -$18.8M 0.04% 544
2019
Q2
$142M Buy
930,308
+53,125
+6% +$8.12M 0.04% 500
2019
Q1
$141M Sell
877,183
-95,853
-10% -$14.9M 0.04% 495
2018
Q4
$150M Buy
973,036
+156,108
+19% +$24.3M 0.05% 424
2018
Q3
$123M Buy
816,928
+614
+0.1% +$87.2K 0.03% 637
2018
Q2
$110M Sell
816,314
-137,516
-14% -$17M 0.03% 667
2018
Q1
$127M Sell
953,830
-126,051
-12% -$16.9M 0.03% 636
2017
Q4
$161M Sell
1,079,881
-74,939
-6% -$10.2M 0.04% 552
2017
Q3
$152M Sell
1,154,820
-38,811
-3% -$5.21M 0.04% 562
2017
Q2
$159M Buy
1,193,631
+158,661
+15% +$21.4M 0.04% 510
2017
Q1
$140M Buy
1,034,970
+138,108
+15% +$17.9M 0.04% 544
2016
Q4
$108M Sell
896,862
-241,580
-21% -$28.5M 0.03% 725
2016
Q3
$143M Sell
1,138,442
-72,954
-6% -$9.56M 0.04% 513
2016
Q2
$168M Buy
1,211,396
+109,246
+10% +$14.2M 0.05% 415
2016
Q1
$139M Buy
1,102,150
+44,336
+4% +$5.64M 0.05% 496
2015
Q4
$134M Buy
1,057,814
+262,456
+33% +$32.6M 0.04% 519
2015
Q3
$91.9M Buy
795,358
+92,942
+13% +$10.4M 0.03% 666
2015
Q2
$73.1M Buy
702,416
+149,663
+27% +$16.1M 0.02% 856
2015
Q1
$61M Sell
552,753
-23,149
-4% -$2.51M 0.02% 952
2014
Q4
$60M Buy
575,902
+42,994
+8% +$4.3M 0.02% 970
2014
Q3
$51.2M Sell
532,908
-195,081
-27% -$17.6M 0.02% 1050
2014
Q2
$66.5M Buy
727,989
+361,843
+99% +$32.4M 0.02% 909
2014
Q1
$32.2M Buy
366,146
+2,545
+0.7% +$223K 0.01% 1379
2013
Q4
$33.7M Buy
363,601
+68,887
+23% +$6.2M 0.01% 1352
2013
Q3
$24.1M Sell
294,714
-110,547
-27% -$9.33M 0.01% 1471
2013
Q2
$33.7M Buy
+405,261
New +$34.9M 0.01% 1150

Other funds holding CLX

Goldman Sachs's CLX Position: Q1 2026 in Review

Goldman Sachs increased its Clorox (CLX) stake by 45% in Q1 2026, buying an estimated $44.5M and bringing the position to 1,258,596 shares worth $130M. The position accounts for 0.02% of the portfolio, ranked #883.

Goldman Sachs first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $210M in Q1 2020. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Goldman Sachs held 1,258,596 shares of Clorox worth $130M as of Q1 2026.
  • Goldman Sachs bought 392,898 Clorox shares in Q1 2026, an estimated $44.5M.
  • Clorox made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #883 holding.
  • Goldman Sachs first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Clorox position peaked at $210M in Q1 2020.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.